Sanguine Biosciences Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Later Stage VC
- Investors
-
22
Sanguine Biosciences General Information
Description
Developer of a translational biomedical and biospecimen collection platform designed for research purposes. The company's platform offers direct-to-patient engagement, in-home collection of annotated biospecimens and apheresis product offerings, enabling researchers to access and conduct prospective study designs and obtain clinically relevant biomarker data.
Contact Information
Website
www.sanguinebio.comCorporate Office
- 3030 Bunker Hill Street
- Suite 119
- San Diego, CA 92109
- United States
Corporate Office
- 3030 Bunker Hill Street
- Suite 119
- San Diego, CA 92109
- United States
Sanguine Biosciences Timeline
Sanguine Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 15-Aug-2024 | Completed | Generating Revenue | |||
| 10. Debt - General | 31-Oct-2023 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 09-Jan-2023 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 16-Mar-2022 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 08-Apr-2020 | Completed | Generating Revenue | |||
| 6. Grant | 01-Feb-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 18-Mar-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Jul-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 29-May-2015 | $5.53M | $7.03M | Completed | Startup | |
| 2. Seed Round | 21-Feb-2013 | $1.5M | $1.5M | Completed | Startup |
Sanguine Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sanguine Biosciences Comparisons
Industry
Financing
Details
Sanguine Biosciences Competitors (2)
One of Sanguine Biosciences’s 2 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Asuragen | Formerly VC-backed | Austin, TX |
Sanguine Biosciences Signals
Sanguine Biosciences Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Albany Capital (Australia) | Venture Capital | Minority | ||
| BroadOak Capital Partners | Growth/Expansion | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| Vitamin Capital | Venture Capital | Minority | ||
| Neman Ventures | Venture Capital | Minority |
Sanguine Biosciences FAQs
-
When was Sanguine Biosciences founded?
Sanguine Biosciences was founded in 2010.
-
Where is Sanguine Biosciences headquartered?
Sanguine Biosciences is headquartered in San Diego, CA.
-
What is the size of Sanguine Biosciences?
Sanguine Biosciences has 120 total employees.
-
What industry is Sanguine Biosciences in?
Sanguine Biosciences’s primary industry is Other Healthcare Technology Systems.
-
Is Sanguine Biosciences a private or public company?
Sanguine Biosciences is a Private company.
-
What is Sanguine Biosciences’s current revenue?
The current revenue for Sanguine Biosciences is .
-
How much funding has Sanguine Biosciences raised over time?
Sanguine Biosciences has raised $27.5M.
-
Who are Sanguine Biosciences’s investors?
Albany Capital (Australia), BroadOak Capital Partners, Catalio Capital Management, Vitamin Capital, and Neman Ventures are 5 of 22 investors who have invested in Sanguine Biosciences.
-
Who are Sanguine Biosciences’s competitors?
Genomic Expression and Asuragen are competitors of Sanguine Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process